Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
Saved in:
| Title: | Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. |
|---|---|
| Authors: | O'Halloran JA; Washington University St Louis, St Louis, Missouri., Ko ER; Duke University Health System, Durham, North Carolina., Anstrom KJ; University of North Carolina, Chapel Hill., Kedar E; St Lawrence Health, Potsdam, New York., McCarthy MW; Weill Cornell Medicine, New York, New York., Panettieri RA Jr; Robert Wood Johnson Medical School, New Brunswick, New Jersey., Maillo M; Sanatorio Diagnostico, Santa Fe, Argentina., Nunez PS; Hospital Nacional Hipolito Unanue, Lima, Peru., Lachiewicz AM; University of North Carolina, Chapel Hill., Gonzalez C; National Center for Advancing Translational Sciences, Bethesda, Maryland., Smith PB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., de Tai SM; Hospital Central de la Fuerza Aerea del Peru, Lima, Peru., Khan A; Oregon Health and Science University, Portland., Lora AJM; University of Illinois at Chicago., Salathe M; University of Kansas Medical Center, Kansas City., Capo G; Trinitas Hospital, Elizabeth, New Jersey., Gonzalez DR; Nuevo Hospital Civil de Guadalajara Juan I. Menchaca, Guadalajara, Mexico., Patterson TF; University of Texas Health Science Center at San Antonio., Palma C; University of Rochester School of Medicine and Dentistry, Rochester, New York., Ariza H; Clinica Central SA, Villa Regina, Argentina., Lima MP; Hospital e Maternidade Celso Pierro-PUC Campinas, Campinas, Brazil., Blamoun J; MidMichigan Medical Center, Midland., Nannini EC; Sanatorio Britanico, Santa Fe, Argentina., Sprinz E; Hospital de Clinicas de Porto Alegre HCPA, Porto Alegre, Brazil., Mykietiuk A; Instituto Medico Platense, La Plata, Argentina., Alicic R; Providence Medical Research Center, Spokane, Washington., Rauseo AM; Washington University St Louis, St Louis, Missouri., Wolfe CR; Duke University Health System, Durham, North Carolina., Witting B; Weill Cornell Medicine, New York, New York., Wang JP; University of Massachusetts Medical Center, Worcester., Parra-Rodriguez L; Washington University St Louis, St Louis, Missouri., Der T; Duke University Health System, Durham, North Carolina., Willsey K; Weill Cornell Medicine, New York, New York., Wen J; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Silverstein A; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., O'Brien SM; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Al-Khalidi HR; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Maldonado MA; Bristol Myers Squibb, Philadelphia, Pennsylvania., Melsheimer R; Janssen Pharmaceuticals, Leiden, the Netherlands., Ferguson WG; AbbVie, Inc, North Chicago, Illinois., McNulty SE; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Zakroysky P; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Halabi S; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Benjamin DK Jr; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina., Butler S; Technical Resources International (TRI), Bethesda, Maryland., Atkinson JC; National Center for Advancing Translational Sciences, Bethesda, Maryland., Adam SJ; Foundation for the National Institutes of Health, Bethesda, Maryland., Chang S; National Center for Advancing Translational Sciences, Bethesda, Maryland., LaVange L; University of North Carolina, Chapel Hill., Proschan M; National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Bozzette SA; National Center for Advancing Translational Sciences, Bethesda, Maryland., Powderly WG; Washington University St Louis, St Louis, Missouri. |
| Corporate Authors: | ACTIV-1 IM Study Group Members |
| Source: | JAMA [JAMA] 2023 Jul 25; Vol. 330 (4), pp. 328-339. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2023.11043 |
